Ryan Sullivan, M.D.


Physician Investigator (Cl)
CCR Group C Monthly, Research Institute
Associate Professor of Medicine
Harvard Medical School
Assistant In Medicine
Hematology-Oncology, Massachusetts General Hospital
MD University of Connecticut School of Medicine 2001
braf; dabrafenib; giant lymph node hyperplasia; herpesviridae infections; herpesvirus 8 human; lymphoma primary effusion; melanoma; molecular targeted therapy; navitoclax; proto-oncogene proteins b-raf; sarcoma kaposi; skin neoplasms; trametinib; vemurafenib

Ryan Sullivan is a clinical and translational investigator whose main areas of interest are the development of novel molecular therapeutic agents for malignant melanoma, the translation of promising preclinical findings into early stage clinical trials, and the development of predictive biomarkers for these investigational as well as standard treatment approaches.

Publications Clinical Profile
rsullivan7@mgh.harvard.edu
6176433614

Yawkey Center Outpatient Care
32 Fruit Street
Boston, MA 02114